Viracta Therapeutics, Inc. - COM (VIRX)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
9.02M
Holdings value Q2 2024
$4.9M
Value change Q2 2024
-$214K
Grand Portfolio weight change Q2 2024
0%
Number of holders
35
Number of buys Q2 2024
8
Number of sells Q2 2024
-11
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 37.3K $8.64K +$2.31K $0.23 2
2024 Q2 9.02M $4.9M -$214K $0.54 35
2024 Q1 9.39M $9.58M -$308K $1.02 39
2023 Q4 9.75M $5.56M -$28.5K $0.57 40
2023 Q3 9.69M $10.1M -$320K $1.04 39
2023 Q2 9.97M $14.1M -$3.56M $1.41 40
2023 Q1 12.2M $19.4M -$224K $1.59 47
2022 Q4 12.4M $18.1M -$595K $1.46 54
2022 Q3 12.4M $52.8M +$4.22M $4.27 53
2022 Q2 11.4M $44.1M -$5.94M $3.88 52
2022 Q1 12.9M $61.6M -$4.25M $4.76 62
2021 Q4 14.2M $51.6M -$12.4M $3.65 62
2021 Q3 15.5M $124M +$15.3M $8.02 64
2021 Q2 13.4M $151M +$41.8M $11.34 57
2021 Q1 9.93M $91.8M +$91.8M $9.25 43